[artículo] 
inJournal of the American Academy of Child & Adolescent Psychiatry > Año 2019 - Vol. 58 - No.11 (Noviembre) . - pp. 1062-1078

Título :	Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole : 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial
Tipo de documento:	texto impreso
Autores:	Jensen Karsten Gjessing, Autor
Fecha de publicación:	2019
Artículo en la página:	pp. 1062-1078
Idioma :	Inglés (eng)
Palabras clave:	Primer episodio de psicosis, Glucosa, Lípidos, Antipsicóticos, Predictores
Resumen:	To investigate cardiometabolic effects and their predictors in youths with first-episode psychosis (FEP) treated with quetiapine-extended release (ER) versus aripiprazole.
Link:	./index.php?lvl=notice_display&id=21303

[artículo] Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole : 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial [texto impreso] / Jensen Karsten Gjessing, Autor . - 2019 . - pp. 1062-1078.
Idioma : Inglés (eng)
in Journal of the American Academy of Child & Adolescent Psychiatry > Año 2019 - Vol. 58 - No.11 (Noviembre) . - pp. 1062-1078

Palabras clave:	Primer episodio de psicosis, Glucosa, Lípidos, Antipsicóticos, Predictores
Resumen:	To investigate cardiometabolic effects and their predictors in youths with first-episode psychosis (FEP) treated with quetiapine-extended release (ER) versus aripiprazole.
Link:	./index.php?lvl=notice_display&id=21303